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SUMMARY
Background
Many coeliac disease patients with atypical symptoms remain undiag-
nosed.
Aim
To examine the frequency of oral lesions in coeliac disease patients and
to assess their usefulness in making coeliac disease diagnosis.
Patients and methods
One hundred and ninety-seven coeliac disease patients and 413 controls
were recruited and the oral examination was performed.
Results
Forty-six out of 197 coeliac disease patients (23%) were found to have
enamel defects vs. 9% in controls (P < 0.0001). Clinical delayed erup-
tion was observed in 26% of the pediatric coeliac disease patients vs.
7% of the controls (P < 0.0001). The prevalence of oral soft tissues
lesions was 42% in the coeliac disease patients and 2% in controls
(P < 0.0001). Recurrent aphthous stomatitis disappeared in 89% of the
patients after 1 year of gluten-free diet. Multi-logistic analysis selected
the following variables as the most meaningful in coeliac disease
patients: dental enamel defects (OR = 2.652 CI = 1.427–4.926) and soft
tissue lesions (OR = 41.667, CI = 18.868–90.909). Artificial Neural Net-
works methodology showed that oral soft tissue lesions have sensitiv-
ity = 42%, specificity = 98% and test accuracy = 83% in coeliac disease
diagnosis.
Conclusions
The overall prevalence of oral soft tissue lesions was higher in coeliac
disease patients (42%) than in controls. However, the positive-predictive
value of these lesions for coeliac disease diagnosis was low.
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INTRODUCTION
Coeliac disease (CD), one of the most common chronic
diseases among Caucasians, is an autoimmune entero-
pathy triggered by the ingestion of gluten-containing
grains in genetically predisposed subjects. During
recent decades, the use of serological assays with a
good diagnostic accuracy has shown that its frequency
is much higher than previously considered, ranging
between 1:85 and 1:300 both in Europe and in the
USA.1–7 At the same time, it has become evident that
the ‘typical’ clinical presentation of CD, i.e. the malab-
sorption syndrome, is nowadays less frequent and
many CD patients show ‘atypical’ – non-gastroentero-
logical – symptoms or are asymptomatic8–12. This dif-
ferent clinical presentation makes diagnosis difficult; in
fact, a serological screening study revealed that the
ratio of known CD cases to undiagnosed CD cases was
1–7.13 Lack of diagnosis may have important conse-
quences as dietary avoidance of gluten determines
remission of the disease and avoids the onset of malig-
nancy and thus decreases mortality in CD patients.14–16
Consequently, paediatricians, gastroenterologists and
internists must look beyond the intestine to suspect a
CD diagnosis. In fact, haematological, dermatological,
neurological, obstetric, gynecological and the most
proteiform clinical presentations of CD should be con-
sidered.17, 18 In this respect, the oral cavity, an appara-
tus which is very easy to examine, can be very
interesting. In fact, mainly recurrent aphthous stomati-
tis (RAS) and dental enamel defects have been reported
to be associated with CD.19–24
The primary aim of this study was to assess the fre-
quency of oral diseases, including soft and hard tissue
lesions in CD patients, in comparison with otherwise
healthy controls; the secondary objective was to con-
sider what contribution an oral clinical examination
could give to help suspect a CD diagnosis.
PATIENTS AND METHODS
The total study population of this prospective study
consisted of 610 subjects; of these, 197 were CD
patients, recruited at the time of diagnosis. They were
consecutively enrolled, between January 2004 and
June 2005: the adult patients (90 cases: 65 F, 25 M,
age range 18–75 years, median 31) in two centres –
gastroenterology and internal medicine – of the Uni-
versity Hospital of Palermo and the children (107
cases: 59 F, 48 M, age range 2–17 years, median
9 years) in the Pediatric Gastroenterology Unit of the
‘Di Cristina Hospital’ in Palermo.
Coeliac disease patients aged under 2 years were
excluded.
Four hundred and thirteen healthy subjects who were
age ⁄ sex-matched (180 adults: 130 F, 50 M age range
19–77 years, median 32; 233 children: 120 F, 113 M,
age range 2–17 years, median 8.5) and living in the
same geographical area as that of the CD group were
enrolled as controls. Paediatric controls were recruited
(by simple randomization) at a day nursery, and at Pri-
mary and Secondary Schools during a health prevention
programme for oral diseases; these subjects did not refer
any diseases, had no family history of CD and showed
normal growth (weight ⁄height ratio between 25th and
75th centiles). Adult controls were recruited among
otherwise healthy patients consecutively referred to the
Dental Unit of the University of Palermo for third molar
surgery; they were tested for serum anti-transglutamin-
ase (anti-tTG) antibodies and were negative.
Coeliac disease diagnosis was based on the positivity
of serum anti-tTG and ⁄or anti-endomysium (EmA)
antibodies, presence of clinical symptoms and positive
histological evidence of villous atrophy with crypt
hyperplasia and increase in intraepithelial lymphocytes
on a gluten-containing diet, and the disappearance of
the symptoms and normalization of serum anti-tTG
and ⁄or EmA on a gluten-free diet (GFD).25
The clinical manifestations of CD were classified as
‘typical’ when they included: chronic diarrhoea, failure
to thrive, anorexia, abdominal distension and muscle
wasting; other clinical manifestations were considered
‘atypical’.17 When CD diagnosis was made in subjects
who were apparently asymptomatic, it was classified
as ‘silent’.
Immediately after CD diagnosis, the patients under-
went an intra-oral examination of the soft and hard
tissues. All evaluations were performed independently
by two of the authors (C. D. and D. L. C., who were
trained in oral health survey) and then tested for con-
cordance.
We focused on hard tissue lesions (i.e. dental enamel
defects), soft tissue lesions (e.g. presence of RAS, aspe-
cific atrophic glossitis and geographic tongue) and
clinical delay of dental eruption.
The enamel defects affecting deciduous and perma-
nent teeth were graded 0–IV according to Aine’s clas-
sification.26 As regard RAS, we included recurrent
ulcerative lesions clinically observed by two of the
authors (C. D. and D. L. C.) during the intra-oral
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examination. However, as clinical evidence of the
lesions is not always found because healing occurred
before the oral investigation, but patients could have
had a past history of aphthous ulcers, we also consid-
ered ulcerative events, noted by parents or patients, or
reported in hospital clinical records, with clinical
features pathognomonic of RAS.
To evaluate delayed eruption in the paediatric
patients, we used the conventional eruption tables for
the Caucasian population27 and we considered delayed
eruption as when the teeth were not in arch after their
normal age of eruption, with a range of 6 months.
In all individuals, dental hygiene was categorized
into nominal variables using three values: 0 (poor),
1 (sufficient) and 2 (good).28
All CD patients with oral soft tissue lesions were
re-evaluated 1 year after the beginning of GFD.
Finally, all the paediatric controls positive for oral
hard and ⁄or soft tissue lesions potentially associated
with CD were tested for anti-tTG antibodies to exclude
the disorder.
Informed consent was obtained for all participants
in the study and the study was approved by the Ethics
Committee of the University Hospital of Palermo.
Statistical analysis
Data were analysed by means of SAS for Windows ver.
9.0, (SAS Institute Inc., Cary, NC, USA) and by means
of STATISTICA 6.0 (Statsoft Inc., Tulsa, USA). To measure
the association level, crude odds ratio (OR) and the
95% corresponding test-based CI were calculated. Stu-
dent’s t-test was used to calculate significant differ-
ences between cases and controls at baseline for
normally distributed variables. The Mann–Whitney
U-test was used to calculate differences between not-
normally distributed variables (e.g. Aine’s scores).
The concordance rate of the oral evaluation between
the observers was evaluated using Cohen’s kappa sta-
tistic, measuring agreement beyond that expected by
chance (expressed as a coefficient ranging from 0 to
1.00).29
The relationship between CD and other variables
was analysed within conditional multivariate frame-
works.
A conditional logistic regression model was con-
structed stratified by age and dental hygiene; the same
model permitted a stepwise selection procedure to
obtain the most parsimonious model. The maximum
likelihood ratio and adjusted OR were obtained using
the iterative weighted least squares procedure. In all of
the evaluations, P-values £0.05 were considered statis-
tically significant.
Furthermore, in a blind manner, three Artificial
Neural Network (ANNs) models were applied to the
same data, as previously described.30 Fully-connected
multilayer feedforward networks were used. The learn-
ing rule employed was the well-known back-error
propagation, which adjusts the internal parameters of
the networks over the repeated training cycles to
reduce the overall error.31 The networks were validated
with a new set of data, different from the training
ones. The performance measured by mean squared
error (MSE), accuracy, sensitivity and specificity values
as well as the receiver operating characteristic (ROC)
area, which can ascertain the degree of meaningful
prediction,32, 33 was calculated for the significant asso-
ciations. In this study, all variables were selected as
input ones, except for CD (the output variable) for
ANNs system analysis.
RESULTS
There was a substantial agreement (kappa = 0.85)
between the observers for the main dental and oral
lesions.
Table 1 summarizes the main findings of the oral
examination in CD patients and controls.
Forty-six out of 197 CD patients (23%) were found
to have systematic and symmetrical enamel defects vs.
a lower rate of 9% (37 ⁄413) in controls [P < 0.0001;
OR = 3.510 (95% CI = 2.135:5.770)]. The frequency of
the enamel defects was very similar in the adult and
paediatric CD patients. The severity of enamel defects
in CD patients, evaluated according to Aine (17), was:
grade I in 87%, grade II in 11% and grade IV in 2%.
Figure 1a,b shows grades 1 and 4 lesions, respectively,
observed in CD patients who were included in the
study.
Clinical delayed eruption was observed in 28 out of
107 paediatric CD patients (27%) vs. 16 out of 233
(7%) controls [P < 0.0001; OR = 5 .932 (95%
CI = 3.407:10.330)].
The overall prevalence of oral soft tissue lesions was
42% (82 ⁄197) in CD patients and 9 ⁄413 in controls
(2%) [P < 0.0001; OR = 22.257 (95% CI =
13.828:35.824)]; frequency was similar in adult and
paediatric CD. RAS was found in 37 ⁄197 (19%) CD
patients vs. 3 ⁄413 (1%) controls [P < 0.0001;
OR = 18.9505 (95% CI = 9.552:37.595)]. In CD
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patients, RAS was directly observed during the medical
visit in 34 cases and simply recalled by the parents in
three cases. Figure 1c,d shows an image of RAS
observed in CD patients who were included in the
study. The other soft tissue lesions detected were aspe-
cific atrophic glossitis and geographic tongue. The first
was found in 31 ⁄197 (16%) CD patients vs. 1 ⁄413
(0.2%) controls [P < 0.0001; OR = 22.464 (95%
CI = 10.500:48.063)], while geographic tongue was
noted in 14 ⁄197 (7%) CD patients vs. 5 out of 413
(1%) controls [P < 0.0001; OR = 7.0326 (95%
CI = 2.650:18.666)]. CD patients showed a better den-
tal hygiene status than controls [P < 0.0001;
OR = 4.848 (95% CI = 2.7027:8.695)].
None of paediatric controls with oral hard and ⁄or
soft tissue lesions presented positive serological mark-
ers for CD.
As regards the clinical manifestations of CD, ‘typi-
cal’ symptoms were more often observed in children
(60 ⁄107 cases, 56%) than in adults (40 ⁄90 cases, 44%),
whereas the frequency of silent cases was similar (7%
in adults vs. 7% in children). However, oral hard or
soft tissue lesions were observed with an almost iden-
tical frequency in patients with ‘typical’ and ‘atypical’
CD symptoms. Furthermore, as among patients without
any signs and symptoms potentially related to CD,
as diagnosed during familial CD screening, we found
cases of oral soft tissue lesions, they should be
Table 1. Oral examination findings in coeliac disease (CD) patients and controls, grouped by adult and paediatric age
Adult individuals Paediatric individuals
CD patients
(n = 90)
Controls
(n = 180) P-value
Unadjusted OR
(95% CI)
CD patients
(n = 107)
Controls
(n = 233) P-value
Unadjusted
OR (95% CI)
Dental enamel defects (%)
No 69 (77) 164 (92) 0.001 3.12 (1.53–6.33) 82 (77) 212 (91) 0.0003 3.07 (1.63–5.80)
Yes 21 (23) 16 (8) 25 (23) 21 (9)
Soft tissue lesions (%)
No 56 (62) 177(97) <0.0001 21.49 (8.02–57.59) 59 (55) 229 (98) <0.0001 46.57 (16.14–134)
Yes 34 (38) 5 (3) 48 (45) 4 (2)
Recurrent aphthous stomatitis (%)
No 71 (79) 179 (99.5) <0.0001 47.36 (6.22–360.53) 89 (83) 231 (99) <0.0001 23.35 (5.31–102)
Yes 19 (21) 1 (0.5) 18 (17) 2 (1)
(a) (b)
(c) (d)
Figure 1. (a) Enamel defects of
upper incisors (arrows indicate
the color changes); (b) Enamel
defects of upper incisors
(structural changes); (c) major
type of recurrent aphthous
stomatitis and (d) numerous
minor-type lesions of RAS.
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considered as patients with ‘atypical’ and not with
‘silent’ CD. In CD patients, the frequency of the oral
hard and ⁄or soft tissue lesions did not differ according
to the severity of intestinal mucosa damage or to the
ideal body weight.
After a 1-year follow-up, 33 out of 37 CD patients
(89%) with RAS at diagnosis referred that they had no
longer suffered from RAS since beginning the GFD.
The other four patients (11%) did not strictly adhere to
GFD, as confirmed by persistently elevated serum anti-
tTG antibodies, and did not report any improvement in
RAS recurrence and number of ulcers per episode.
Also, atrophic glossitis disappeared in all the patients
who adhered to GFD. As regards geographic tongue,
no cases were present in the sample followed longitu-
dinally.
Conditional multi-logistic analysis in the stepwise
procedure selected Oral Mucosa Lesions and Dental
Enamel Hypoplasia as the most meaningful variables
in CD patients (Table 2).
Artificial Neural Networks methodology consistently
proved that CD was the most meaningful variable
related to soft tissue lesions in the present dataset, with
MSE equal to 0.321. Performance indexes showed the
following values: accuracy = 83%; sensitivity = 42%,
specificity = 98%. The ROC area was equal to 0.83.
On the basis of the 3% prevalence of CD recorded in
our centres during the study period, and on the basis
of the sensitivity and specificity shown by the ANN
methodology, the positive and negative predictive val-
ues of the oral lesions were 39% and 99%, respec-
tively. On the basis of the 1% CD prevalence in the
general population, the positive and negative predic-
tive values of the oral lesions in CD diagnosis were
17% and 99%, respectively.
DISCUSSION
Recent epidemiology data have shown a prevalence of
CD approaching 1% in the general population.34–36
However, there has been a noticeable change in the
clinical presentation of CD, as almost 50% of the
patients with newly diagnosed CD do not present with
gastrointestinal (GI) symptoms37, 38 thus making diag-
nosis difficult. This is a paramount aspect as a GFD in
CD patients is known to prevent many of the extra-
intestinal symptoms, such as osteoporosis,39 recurrent
abortions,40 and above all, it protects against the
development of cancer.41 Thus, to identify the greatest
number of ‘atypical’ or ‘silent’ CD patients and prevent
complications, clinicians must investigate ‘at-risk sub-
jects’, e.g. those with chronic anaemia,42, 43 hyper-
transaminasemia or hyperamylasemia of unknown
origin,44, 45 osteoporosis,39 autoimmune thyroid
disorders.46 Furthermore, it is known that CD is an
auto-immune disease resulting from an inappropriate
T cell-mediate immune response against ingested glu-
ten.47 Although the proximal part of the intestinal
mucosa represents the main site of the gut involved in
CD, it has been demonstrated that gluten-driven T-cell
activation is not restricted to the small intestine, but is
present in the whole GI tract. The mouth, the first part
of the GI system, represents a site very easy to detect
and an oral examination could give a useful diagnos-
tic contribution as lesions of the hard48, 49 and soft tis-
sues50, 51 have been reported in CD.
Ours is the largest uni-centre study to have investi-
gated the risk for CD patients of suffering from dental
or oral mucosa lesions and shown the sensitivity and
specificity of oral soft tissue lesions in suggesting a
CD diagnosis.
As regards the hard tissues, we found systematic
and symmetrical enamel defects in 23% of CD
patients, with an OR >3 in comparison with the con-
trols. The enamel defects resulted in a dental defor-
mity, which can be easily recognized (see Figure 1),
although low-grade lesions must also be accurately
investigated. Other studies have reported a wide
range of frequencies of enamel defects in CD
patients,26, 48, 52–59, but our data are in agreement
with other studies performed in Italy, and the differ-
ences in frequency probably depend on environmen-
tal, dietetic and, above all, genetic factors.54 The
same hypothesis could be made for the severity of
enamel defects which appeared less severe in our
study (87% of the patients had a grade I lesion) than
in other studies.48
The aetiopathogenesis of these defects in CD patients
still remains unclear. As the crowns of deciduous
and permanent teeth develop from 4 to 5 months of
Table 2. Conditional multi-logistic analysis in the
stepwise procedure. Characteristics and risk factors were
stratified by age and oral care
Odds ratio 95% CI
Gender (female vs. male) 1.980 1.253–3.130
Dental enamel hypoplasia 2.652 1.427–4.926
Oral soft tissue lesions 41.667 18.868–90.909
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intra-uterine life to the 7th year of life except for the
third molar, nutritional, immunological or genetic fac-
tors (association with the HLA DR3 allele) have been
hypothesized as causing developmental defects in the
enamel.53, 60 Hypocalcaemia caused by malabsorption
during dental development has been considered to be
implicated in enamel hypoplasia. Regarding the nutri-
tional dynamics, despite some doubts raised by Maki
et al.,60 it has been hypothesized that a gluten-induced
immunological process could occur between 6 months
and 7 years in the enamel-producing organ, resulting
in defective enamel formation. Finally, these dental
anomalies have been found to be significantly related
to HLA antigen DR3.53, 56, 60 Furthermore, an Italian
study,53 reporting a frequency of 29% in coeliac
patients vs. 15% in controls, did not report any statis-
tically significant differences in calcium concentra-
tions, but a coincidence in 77% of CD and enamel
defects in DR3-positive subjects. Another finding on
dental hard tissues was the significantly higher fre-
quency of delayed eruption, observed in 27% of CD
children. Only few papers in the literature have dealt
with this issue,49, 61–63 and they are in agreement with
our data. The delayed dental eruption could be seen as
a possible sign of malnutrition (such as is delayed
puberty) and advises for serological CD screening.
However, the most important finding of the present
study is related to the oral soft tissue investigation: in
fact, mucosa lesions were found in 42% of CD patients
with an OR of 22 vs. controls. Within this group of
lesions, RAS was found in 37 ⁄197 (19%) CD patients
with an OR of 19 vs. controls. RAS frequency in CD
observed in our study is in agreement with that
reported by other authors.64, 65 It is also very interest-
ing that almost all (89%) the CD patients with RAS no
longer suffered after beginning GFD and the lack of
healing in the remaining patients was probably linked
to the lack of adherence to GFD. Consequently, RAS
persistence in CD patients could cautiously be consid-
ered a marker of lack of GFD adherence. This hypothe-
sis is supported by a study which reported that RAS
and intestinal histological alterations relapsed after
gluten challenge.66
Although several studies have reported the presence
of oral mucosa lesions in CD, our study reports the
first evaluation of the risk of such lesions in CD
patients using univariate, multi-logistic regression,
ANN sensitivity and specificity testing.
However, despite a good test accuracy, the presence
of oral lesions showed a low positive-predictive value
of 16%, giving in the general population a 1% preva-
lence of CD.
In conclusion, our study showed a higher frequency
of oral alterations in CD patients in comparison with
healthy controls. However, the presence of these lesions
had a low positive-predictive value in CD diagnosis.
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